12:00 AM
Feb 04, 2013
 |  BC Week In Review  |  Company News  |  Deals

Biotecnol Inc., Chiome deal

The companies partnered to co-develop multi-specific Tribody molecules against undisclosed targets to treat cancer using Chiome's ADlib antibody generating system...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >